Literature DB >> 11995464

Topographical distribution of lymph node metastasis in adenocarcinoma of the gastroesophageal junction.

Stefan P Mönig1, Stephan E Baldus, Thomas K Zirbes, Peter H Collet, Wolfgang Schröder, Paul M Schneider, Hans P Dienes, Arnulf H Hölscher.   

Abstract

BACKGROUND/AIMS: The current discussion concerning the extent of resection in patients with adenocarcinoma of the gastroesophageal junction is focused beside the luminal extent of resection primarily on the value of lymphadenectomy.
METHODOLOGY: In order to clarify whether spread of lymph node metastasis shows different pathways in adenocarcinomas of the gastroesophageal junction, a prospective, morphological study of the topographical distribution of lymph node metastasis was performed. Transthoracic en bloc esophagectomy with two-field lymphadenectomy (n = 13) or transhiatal esophagectomy with lymphadenectomy of the lower mediastinum and compartment I (lymph node No. 1-3) as well as II (n = 4) was performed in type I carcinoma and transhiatally extended gastrectomy with D2-lymphadenectomy and lymphadenectomy of the lower mediastinum in type II and III carcinoma (n = 33).
RESULTS: In 50 specimens, 1730 lymph nodes were evaluated with regard to metastatic infiltration. We found metastases in the lymph nodes of the lower mediastinum in 24% of type I carcinoma, in 11% of type II carcinoma and in 13% of type III carcinoma, whereas the lymph nodes of the upper mediastinum were tumor free in all patients with transthoracic en bloc resection and 2-field lymphadenectomy (n = 13). In all cases with lymph node metastasis abdominal lymph nodes were affected independently from the localization of the primary tumor.
CONCLUSIONS: The main direction of lymph node spread in adenocarcinoma of the gastroesophageal junction is towards the abdomen and the lower mediastinum. For precise tumor staging standardized lymphadenectomy of the lower mediastinum and the abdominal compartments I and II is essential.

Entities:  

Mesh:

Year:  2002        PMID: 11995464

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  7 in total

Review 1.  Pattern of lymphatic spread of Barrett's cancer.

Authors:  Marcus Feith; Hubert J Stein; J Rüdiger Siewert
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

2.  Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach?

Authors:  Susanne Blank; Thomas Schmidt; Patrick Heger; Moritz J Strowitzki; Leila Sisic; Ulrike Heger; Henrik Nienhueser; Georg Martin Haag; Thomas Bruckner; André L Mihaljevic; Katja Ott; Markus W Büchler; Alexis Ulrich
Journal:  Gastric Cancer       Date:  2017-07-06       Impact factor: 7.370

Review 3.  Siewert III adenocarcinoma: treatment update.

Authors:  Alberto Di Leo; Andrea Zanoni
Journal:  Updates Surg       Date:  2017-03-16

4.  Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome.

Authors:  Andrew P Barbour; Nabil P Rizk; Mithat Gonen; Laura Tang; Manjit S Bains; Valerie W Rusch; Daniel G Coit; Murray F Brennan
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

Review 5.  Surgical approach to invasive adenocarcinoma of the distal esophagus (Barrett's cancer).

Authors:  J Rüdiger Siewert; Hubert J Stein; Marcus Feith
Journal:  World J Surg       Date:  2003-08-21       Impact factor: 3.352

6.  Occult solitary submucosal jejunal metastasis from esophageal carcinoma.

Authors:  Joerg Lindenmann; Franz Gollowitsch; Veronika Matzi; Christian Porubsky; Alfred Maier; Freyja Maria Smolle-Juettner
Journal:  World J Surg Oncol       Date:  2005-07-16       Impact factor: 2.754

Review 7.  Current surgical treatment of esophagogastric junction adenocarcinoma.

Authors:  Shun Zhang; Hajime Orita; Tetsu Fukunaga
Journal:  World J Gastrointest Oncol       Date:  2019-08-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.